Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Advanced Neuromuscular Medicine Fellowship, Duke University School of Medicine 2016 - 2017
  • Neuromuscular Medicine Fellowship, Neurology, Duke University School of Medicine 2015 - 2016
  • Neurology Residency, Adult Neurology, University of Maryland School of Medicine 2012 - 2015
  • Internship, Medicine, University of Maryland School of Medicine 2011 - 2012
  • M.D., Thomas Jefferson University 2011
• 

  Duke Appointment History

  • Medical Instructor in the Department of Neurology, Neurology, General & Community Neurology, Neurology 2017 - 2018
• Research
• 

  Selected Grants

  • Real World Outcomes of Surgical and Medical Management in Myasthenia Gravis 2019 - 2022
  • Phase I Single Ascending Dose and Multiple Ascending Dose Study of 2R,6R-Hydroxynorketamine awarded by National Institutes of Health 2018 - 2020
  • AANEM Autoimmune Neuromuscular Disorders Fellowship 2017 - 2018
• 

  Industry Relationships

  • UCB Pharma
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Raja SM, Howard JF, Juel VC, Massey JM, Chopra M, Guptill JT. Clinical outcome measures following plasma exchange for MG exacerbation.. Ann Clin Transl Neurol. 2019 Oct;6(10):2114–9.
       Full Text  Link to Item
    • Raja SM, Sanders DB, Juel VC, Harati Y, Smith AG, Pascuzzi R, et al. Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.. Muscle Nerve. 2019 Sep;60(3):292–8.
       Full Text  Link to Item
    • Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, et al. Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.. Neurology. 2018 Jun 5;90(23):e2034–41.
       Full Text  Link to Item
    • Guptill JT, Raja S, Sanders DB, Narayanaswami P. Comparative effectiveness clinical trials to advance treatment of myasthenia gravis.. Ann N Y Acad Sci. 2018 Feb;1413(1):69–75.
       Full Text  Link to Item
    • Sanders DB, Guptill JT, Aleš KL, Hobson-Webb LD, Jacobus DP, Mahmood R, et al. Reliability of the triple-timed up-and-go test.. Muscle Nerve. 2018 Jan;57(1):136–9.
       Full Text  Link to Item
    • Guptill JT, Raja SM, Boakye-Agyeman F, Noveck R, Ramey S, Tu TM, et al. Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects.. J Clin Pharmacol. 2017 Jun;57(6):770–6.
       Full Text  Link to Item
    • Yi JS, Russo MA, Massey JM, Juel V, Hobson-Webb LD, Gable K, et al. B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity.. Front Neurol. 2017;8.
       Full Text  Open Access Copy  Link to Item
    • Chen S, Fu L, Raja SM, Yue P, Peterson YK, Khuri FR, et al. Differential roles of DR4, DR5 and c-FLIP in regulation of geranylgeranyltransferase I inhibitor-induced augmentation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Research. 2009 May 1;69.
       Link to Item
    • Raja SM, Chen S, Yue P, Acker TM, Lefkove B, Arbiser JL, et al. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Molecular Cancer Therapeutics. 2008 Jul 1;7(7):2212–23.
       Full Text

  • Conference Papers

    • Raja S, Juel V, Massey J, Hobson-Webb L, Guptill J, Gable K, et al. Lambert-Eaton Myasthenia With and Without Cancer: Clinical Characteristics and Long-term Survival. In: Neurology. LIPPINCOTT WILLIAMS & WILKINS; 2018.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.